Belgium-listed real estate company Aedifica and UK-listed MedicX Fund will be included in the FTSE EPRA/NAREIT Developed Europe Index as of close-of-business on 15 March.

They passed all eligibility criteria during the index’s March quarterly review with an investability weight of 89 per cent and 100 per cent respectively, according to EPRA.

Stefaan Gielens, chief executive of Aedifica, says: “Being included in the EPRA Index has always been a key milestone we wanted to achieve, especially after the successful rights issue in 2012. We consider it to display a wider recognition of our commitment to best practice, and an opportunity for global investors to play a part in Aedifica’s ongoing success.”

Philip Charls, chief executive of EPRA, says: “We welcome another set of excellent inclusions to the EPRA Index – they now join the leading club of European property companies."